COMMONWEALTH EQUITY SERVICES, LLC

Position in BEAM — Beam Therapeutics Inc.

CIK 312272 WALTHAM, MA

Position in BEAM

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$288,974

+$81,213 QoQ

Shares Held

8,420

+12.3% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#172

of 274 holders

Holding Since

Dec 2020

14 quarters on record

Healthcare · as of Jun 30, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $124,479,036 across 113 Biotechnology names. BEAM ranks #57 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	50,813	$25,240,341
2	TGTX	Tg Therapeutics, Inc.	186,987	$10,273,065
3	REGN	Regeneron Pharmaceuticals, Inc.	14,671	$9,147,955
4	EXEL	Exelixis, Inc.	105,998	$5,767,351
5	TARS	Tarsus Pharmaceuticals, Inc.	79,888	$5,028,150
6	MRNA	Moderna, Inc.	66,546	$4,660,216
7	KRYS	Krystal Biotech, Inc.	12,116	$4,503,153
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,170	$4,496,906

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$288,974	8,420	+12.3%	Shares	Sole	2026-07-29
2025-12-31	$207,761	7,495	-36.8%	Shares	Sole	2026-02-12
2024-03-31	$391,986	11,864	+20.9%	Shares	Sole	2024-04-29
2023-09-30	$235,978	9,812	+11.7%	Shares	Sole	2023-10-23
2023-06-30	$280,409	8,782	+11.6%	Shares	Sole	2023-08-10
2023-03-31	$240,948	7,869	+55.2%	Shares	Sole	2023-05-11
2022-09-30	$241,534	5,070	-19.5%	Shares	Sole	2022-11-14
2022-06-30	$243,950	6,302	-23.1%	Shares	Sole	2022-07-19
2022-03-31	$469,745	8,198	+14.5%	Shares	Sole	2022-05-04
2021-12-31	$570,660	7,161	-7.9%	Shares	Sole	2022-01-31
2021-09-30	$676,415	7,774	+6.6%	Shares	Sole	2021-10-29
2021-06-30	$939,068	7,296	+95.7%	Shares	Sole	2021-08-11
2021-03-31	$298,469	3,729	+31.1%	Shares	Sole	2021-05-04
2020-12-31	$232,184	2,844	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.